Navigation Links
Hologic to Host Investor Reception at RSNA 2009

BEDFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company will host a meeting for members of the investment community at the RSNA (Radiological Society of North America) trade show in Chicago, IL. RSNA is the world's largest medical meeting with over 60,000 radiologists, technologists, administrators and vendors expected to attend. For more information about RSNA, please visit

Hologic's investor meeting will be held on Tuesday, December 1, 2009, at McCormick Place from 8:00 to 10:00 a.m. (Central Time) and will include presentations by members of Hologic's management team, as well as customers using two of Hologic's products.

Interested participants may listen to the call (listen-only mode) by dialing 800-299-7089 or 617-801-9714, passcode 79007028, beginning at 7:50 a.m. (Central Time) and referencing the Hologic Investor Meeting. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Tuesday, December 15, 2009, at 888-286-8010 or 617-801-6888, passcode 92355143.

Interested parties are invited to listen to a live audio webcast of Hologic's presentation on the investor section of the company's website at An archive of the presentation will be available for replay following the event.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit

    Contact: Deborah Gordon
             Vice President, Investor Relations
             Hologic, Inc.
             (781) 999-7716

SOURCE Hologic, Inc.

SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
10. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
11. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 Research and ... the "Membranes Market - Global Forecast to 2020" ... Asia-Pacific , accounting for 37.21% of the total ... Asia-Pacific region is projected to growth ... growth has been attributed primarily to the fast growing ...
(Date:11/25/2015)... 2015 --> ... Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, welches ... innehaben, an Enyo Pharma vergeben haben. Im ... gerufenen und von Edelris gemeinsam mit seinen Partnern Inserm ... für HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, ...
(Date:11/25/2015)... DUBLIN , November 25, 2015 ... has announced the addition of the  ... 2015-2019"  report to their offering.  ... announced the addition of the  "Global ...  report to their offering.  ...
Breaking Medicine Technology:
(Date:11/24/2015)... , ... November 24, 2015 , ... DMG Productions announced ... Begley Jr., airing first quarter 2016 via Discovery Channel. Dates and show times TBA. ... Province, and is in the business of producing and supplying medical marijuana pursuant to ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... LENR HHT Bolier Reactor System. Brillouin is the developer of renewable energy technologies ... low energy nuclear reactions (“LENR”), announced today that its WET™ and HHT™ Boiler ...
(Date:11/24/2015)... ... 2015 , ... American Family Care (AFC), the nation’s leading provider of urgent ... located in Metro Atlanta’s North Point Mall. The clinic is designed to test the ... is scheduled to operate through Dec. 24. , Holiday Pop-Up Clinic , Official Opening ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... been designated an Aetna Institute of Quality® Bariatric Surgery Facility for treating individuals ... and cost of health care services available to its members to help them ...
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL LEADERSHIP: ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November 24, ... patients and their families, shaped my desire to improve the system of care. I ...
Breaking Medicine News(10 mins):